273 related articles for article (PubMed ID: 22172449)
1. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.
Herring N; Cranley J; Lokale MN; Li D; Shanks J; Alston EN; Girard BM; Carter E; Parsons RL; Habecker BA; Paterson DJ
J Mol Cell Cardiol; 2012 Mar; 52(3):667-76. PubMed ID: 22172449
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.
Moriarty M; Gibbins IL; Potter EK; McCloskey DI
Neurosci Lett; 1992 May; 139(2):275-9. PubMed ID: 1376882
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.
Smith-White MA; Wallace D; Potter EK
J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119
[TBL] [Abstract][Full Text] [Related]
5. Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.
Smith-White MA; Iismaa TP; Potter EK
Br J Pharmacol; 2003 Sep; 140(1):170-8. PubMed ID: 12967946
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.
Herring N; Paterson DJ
J Physiol; 2001 Sep; 535(Pt 2):507-18. PubMed ID: 11533140
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
Serone AP; Wright CE; Angus JA
Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
[TBL] [Abstract][Full Text] [Related]
8. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
Ilebekk A; Björkman JA; Nordlander M
J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
Serone AP; Angus JA
Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.
Courtice GP; Potter EK; McCloskey DI
J Physiol; 1993 Feb; 461():379-86. PubMed ID: 7688807
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional cardiac cholinergic deficits in adult neurturin knockout mice.
Mabe AM; Hoover DB
Cardiovasc Res; 2009 Apr; 82(1):93-9. PubMed ID: 19176599
[TBL] [Abstract][Full Text] [Related]
14. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.
Revington M; Potter EK; McCloskey DI
J Physiol; 1990 Dec; 431():495-503. PubMed ID: 1712845
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.
Potter E
Neurosci Lett; 1987 Dec; 83(1-2):101-6. PubMed ID: 3441289
[TBL] [Abstract][Full Text] [Related]
16. [Presynaptic regulation of co-release of neuropeptide Y and noradrenaline induced by electrical stimulation of the sympathetic nerve in guinea pig heart].
Cheng B; Haass M; Richardt G; Schömig A
Zhonghua Yi Xue Za Zhi; 1991 Oct; 71(10):564-7, 38. PubMed ID: 1665390
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and neuropeptide Y coexist in non-noradrenergic sympathetic neurons to guinea pig trachea.
Bowden JJ; Gibbins IL
J Auton Nerv Syst; 1992 Apr; 38(1):1-19. PubMed ID: 1588001
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
Mahns DA; Lacroix JS; Potter EK
J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
[TBL] [Abstract][Full Text] [Related]
19. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
Warner MR; Levy MN
Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
